Application 207189
- Type
- ANDA
- Sponsor
- CIPLA LTD
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | DARUNAVIR | DARUNAVIR | TABLET;ORAL | 75MG | No | No |
| 002 | DARUNAVIR | DARUNAVIR | TABLET;ORAL | 150MG | No | No |
| 003 | DARUNAVIR | DARUNAVIR | TABLET;ORAL | 400MG | No | No |
| 004 | DARUNAVIR | DARUNAVIR | TABLET;ORAL | 600MG | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Darunavir | DARUNAVIR | Bryant Ranch Prepack | e80e44f8-1987-4b78-a63d-a4e4d5122ddb | 2026-03-11 | Warnings, Adverse reactions | Darunavir DARUNAVIR |
| Darunavir | DARUNAVIR | NuCare Pharmaceuticals, Inc. | 42cc1b58-2660-f0be-e063-6394a90abe4c | 2025-11-05 | Warnings, Adverse reactions | Darunavir DARUNAVIR |
| DARUNAVIR | DARUNAVIR | Lupin Pharmaceuticals, Inc. | 56daf67e-7501-4cd5-be22-566d7997d42e | 2025-10-23 | Warnings, Adverse reactions | DARUNAVIR DARUNAVIR |
| PREZISTA | DARUNAVIR | Janssen Products LP | 814301f9-c990-46a5-b481-2879a521a16f | 2025-08-29 | Warnings, Adverse reactions | DARUNAVIR |
| Darunavir 600 and 800 mg | DARUNAVIR | Bryant Ranch Prepack | bf99d8b8-c4e0-4cb4-924e-8cdcfd8d1aa1 | 2025-06-05 | Warnings, Adverse reactions | DARUNAVIR |
| Darunavir | DARUNAVIR | Camber Pharmaceuticals, Inc. | 49606d5e-f45f-45eb-9ab8-15aa6a233875 | 2025-03-19 | Boxed warning, Warnings, Adverse reactions | Darunavir DARUNAVIR |
| Darunavir | DARUNAVIR | Aurobindo Pharma Limited | 88910ad0-6dc3-4a47-8a6b-5c6ee79f2a93 | 2024-06-22 | Warnings, Adverse reactions | Darunavir DARUNAVIR |
| Darunavir | DARUNAVIR | Zydus Lifesciences Limited | 6a029063-b14c-4eee-9958-0d9eecb27726 | 2024-04-29 | Darunavir DARUNAVIR | |
| Darunavir | DARUNAVIR | Viona Pharmaceuticals Inc | 04a542b3-15ad-4a8a-aab4-ace8e08732f3 | 2024-04-29 | Warnings, Adverse reactions | Darunavir DARUNAVIR |
| darunavir | DARUNAVIR 600 MG | EXELAN PHARMACEUTICALS INC. | ed977166-7ac0-4a8c-a10c-4b19a69403c0 | 2024-01-19 | Warnings, Adverse reactions | darunavir |
| Darunavir 600 and 800 mg | DARUNAVIR | Cipla USA Inc. | 5624cc30-d484-458e-b234-9bb745a118ca | 2024-01-18 | Warnings, Adverse reactions | DARUNAVIR |
| Darunavir | DARUNAVIR | Novadoz Pharmaceuticals LLC | ea6e0136-75b2-4793-9500-04e6658a0a73 | 2023-11-29 | Warnings, Adverse reactions | Darunavir DARUNAVIR |
| Darunavir | DARUNAVIR | Dr.Reddys Laboratories Inc | f5c9cb01-6530-4db0-a326-22a499d1efdf | 2023-11-25 | Warnings, Adverse reactions | Darunavir DARUNAVIR |
| Darunavir | DARUNAVIR | Amneal Pharmaceuticals NY LLC | 92b286d5-1ee5-435b-9e1d-2e95c7f2ec69 | 2023-11-21 | Warnings, Adverse reactions | Darunavir DARUNAVIR |
| Darunavir | DARUNAVIR | Camber Pharmaceuticals, Inc. | 64160982-e682-4e8d-8800-a89321112211 | 2023-10-05 | Warnings, Adverse reactions | Darunavir DARUNAVIR |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.